Guiding the Science, Purpose, and Progress Behind Aurion Biotech

Experienced Leaders Driving Our Mission

Aurion Biotech’s leadership team brings together deep expertise across ophthalmology, regenerative medicine, clinical development, regulatory affairs, manufacturing, and global commercialization. We are guided by a mission to restore vision for patients worldwide.

Leadership

Medical Advisors

Board of Directors

Leadership Team

Arnaud Lacoste, PhD, MBA

CEO and Chief Scientific Officer

Dr. Arnaud Lacoste is Co-founder, Chief Executive Officer and Chief Scientific Officer at Aurion Biotech, where he leads the company’s strategic vision and scientific innovation in regenerative cell therapy for corneal disease.

Eris P. Jordan, OD

Chief Development Officer

Dr. Eris Jordan is Co-founder and Chief Development Officer at Aurion Biotech, where she leads clinical development and professional affairs for the company’s regenerative cell therapy targeting corneal endothelial disease.

Edward J. Holland, MD

Chief Medical Officer

In addition to his role at Aurion Biotech, Dr. Edward Holland is the director of Cornea Services at Cincinnati Eye Institute and professor of ophthalmology at the University of Cincinnati.

Andrew Torres, PhD

Chief Manufacturing Officer

Dr. Andrew Torres serves as Chief Technical Officer at Aurion Biotech, where he leads all aspects of chemistry, manufacturing, and controls (CMC) for the company’s cell therapy platform.

Sterling Chung

Chief Regulatory & Quality Officer

Sterling Chung manages Regulatory Affairs and Quality for Aurion Biotech, Inc. He has more than 20+ years of industry experience, encompassing a broad range of functions including Regulatory Affairs, Quality Assurance, Pharmacovigilance, Medical Writing and Publications.

Brad Shutzberg

Vice President Finance & Infrastructure

Brad Shutzberg is the Vice President, Finance & Infrastructure at Aurion Biotech, responsible for managing the Finance, Facilities, and IT functions.

Sara Rosetti, PhD

Vice President Human Resources

Dr. Sara Rosetti leads the HR organization at Aurion. Her focus is on building organizational capability through attracting, retaining and developing individual employees, people managers and leaders.

J.D. Osborne, MBA

Vice President, Alliance Management

J.D. Osborne is Vice President of Alliance Management at Aurion Biotech, where he leads the strategy, execution, and oversight of key external partnerships supporting the development and future commercial launch of the company’s endothelial cell therapy.

Jen Watts, M.S.

Vice President, Global Head of Clinical Operations

Jen Watts brings more than two decades of global leadership in clinical operations and development to Aurion Biotechnology.

Heidi Chandler

Executive Director, Head of Program Management

Heidi Chandler is Head of Program Management at Aurion Biotech, where she leads development planning and execution while driving cross-functional alignment across the company’s pipeline.

Medical Advisors

Marjan Farid, MD

Dr. Marjan Farid is director of the cornea, cataract, and refractive surgery and vice chair of ophthalmic faculty at the Gavin Herbert Eye Institute at the University of California Irvine. Dr. Farid graduated summa cum laude from UCLA with a degree in Biology. She earned her medical degree at UC San Diego in 2002. She then came to UC Irvine where she went on to complete her residency and fellowship training in cornea under the mentorship of Dr. Roger Steinert.

Shigeru Kinoshita, MD, PhD

Professor Shigeru Kinoshita, MD, PhD, graduated from Osaka University Medical School in 1974. In 1992, he was appointed professor and chair of the department of ophthalmology at Kyoto Prefecture University of Medicine (KPUM). Since 2015, he has held the title of professor and chair in the department of frontier medical science and technology for ophthalmology at KPUM.

Richard Lindstrom, MD

Dr. Richard Lindstrom is the founder and attending surgeon at Minnesota Eye Consultants, Adjunct Clinic Professor Emeritus at the University of Minnesota Department of Ophthalmology and visiting professor at the UC Irvine Gavin Herbert Eye Institute. Dr. Lindstrom is a board-certified ophthalmologist and internationally recognized leader in corneal, cataract, refractive, glaucoma and laser surgery. He has been at the forefront of ophthalmology’s evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon.

John Berdahl, MD

Dr. John Berdahl specializes in advanced cataract, corneal and glaucoma surgery at Vance Thompson Vision in Sioux Falls, South Dakota. He earned his medical doctorate, graduating with honors from Mayo Medical School in Rochester, Minnesota, and finished his internship at the Mayo Clinic in Scottsdale, Arizona. He completed an ophthalmology residency at Duke University where his published work, research, teaching and care of patients brought him many honors, including best resident and national recognition as first-place winner of the Resident Writers Award. Dr. Berdahl pursued additional advanced surgical training at one of the most coveted cornea and glaucoma fellowships in the country at Minnesota Eye Consultants. As a fellow he received the Claes Dohlman Award from Harvard University, which is given to the top cornea fellow in the country.

Clara Chan, MD

Dr. Clara Chan is a specialist in cornea, cataract and refractive surgery. She is currently a Professor of Ophthalmology at the University of Toronto and the President of the Canadian Cornea, External Disease and Refractive Surgery Society. She teaches fellows as part of the Cornea fellowship program at the Toronto Western Hospital and is the Medical Director of the Eye Bank of Canada, Ontario Division.

Deepinder K. Dhaliwal, MD, L.Ac

Deepinder K. Dhaliwal, MD, L.Ac, is professor of Ophthalmology at the University of Pittsburgh School of Medicine, chief of Refractive Surgery, and vice chair of the Department of Ophthalmology for Wellness and Communications. Dr. Dhaliwal also serves as the director of the UPMC Vision Institute’s Laser Vision Center, the associate medical director of the Campbell Ophthalmic Microbiology Laboratory and the Clinical co-director of the Corneal Regeneration Laboratory at the University of Pittsburgh.

Jose Güell, MD

Dr. Jose L. Güell is the director of the cornea and refractive surgery unit at the Instituto de Microcirugia Ocular de Barcelona (IMO). He studied Medicine and Surgery at the Universitat de Barcelona (UB). Dr. Guell completed his residency at UAB Vall d’Hebrón and a clinical fellowship in cornea and refractive surgery at Emory University. Prior to IMO, Dr. Guell was the director of cornea and refractive surgery in the ophthalmology department of the Vall d’Hebrón Hospital.

Board of Directors

Ed McGough

Ed McGough is Senior Vice President, Global MTO Advisor for Alcon. He served as SVP, MTO from January 1, 2008, until January 1, 2025.

Joe Rappon, MS, OD

Dr. Joe Rappon serves as the Vice President and Head of Alcon’s R&D Pharma Platform, leading the pharmaceutical research and development organization and technical capabilities.

Thomas Hudnall

Thomas Hudnall is Vice President – Corporate Legal and Assistant Corporate Secretary at Alcon, a global leader in ophthalmology.

Jeannette Bankes

Jeannette Bankes is the President & CEO of GE HealthCare’s Patient Care Solutions segment, a $3.1 billion business that provides innovations in Monitoring Solutions, Diagnostic Cardiology, Maternal Infant Care and Anesthesia solutions.

Matthew Snakenberg

Matthew Snakenberg has extensive experience in business development, licensing, and mergers and acquisitions.

Christine Z. McCauley

Christine McCauley is Corporate Vice President, Global Human Resources, for Edwards Lifesciences.

Supported by Alcon, the global leader in eye care dedicated to helping people see brilliantly

Expanding the Reach of Every Donor Cornea

Aurion Biotech collaborates with clinicians, researchers, and partners committed to advancing the future of corneal treatments. Get in touch to learn more about our science, programs, and global mission.